Fresenius Kabi
Sudeshn Pan, Ph.D., MBA, is an experienced professional in business development with a strong background in the pharmaceutical industry. Currently serving as the Director of Business Development & Projects at Fresenius Kabi since July 2019, Sudeshn previously held roles at Novartis as Portfolio & Launch, BD&L from September 2016 to June 2019, and at Healol Pharmaceuticals, where Sudeshn was the Director of Business Development and General Manager from June 2006 to August 2016. Prior experience includes serving as the National Sales & Marketing Manager at Healol Pharmaceuticals and as a Territory Manager at Eli Lilly and Company. Sudeshn's educational credentials include a Doctor of Philosophy (Ph.D.) in Health Economics and Management from the University of Tun Abdul Razak, an MBA from the Asian Institute of Management, a degree in Entrepreneurship in Emerging Economies from Harvard University, and a B.Sc in Life Science from the Government Autonomous Science College, Jabalpur.
This person is not in any teams
This person is not in any offices
Fresenius Kabi
16 followers
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. Fresenius Kabi’s product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, Fresenius Kabi focuses on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell therapies, Fresenius Kabi offers products for collection of blood components and extracorporeal therapies.